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ABSTRACT 
 
Background and Objectives: The cytotoxin-associated gene (cag) pathogenicity island is reported to be a major virulence 
factor of Helicobacter pylori infection. It is previously reported that the cagA-positive strains are more virulent, so it can 
be postulated that the cagA-positive gastritis will be more severe and the serum immunoglobulin G (IgG) and A (IgA) an-
ti-CagA antibody titer will be higher. The aim of this study was to compare the relationship between IgG and IgA anti-CagA 
antibody and the cagA gene expression in patients with dyspepsia. Serum samples obtained from 130 dyspeptic patients 
with positive H. pylori in histological and Geimsa staining were tested for serum IgG and IgA anti-CagA antibody using the 
enzyme-linked immunosorbent Assay. The expression of the cagA gene was determined using PCR on the biopsy samples, 
taken via endoscopy.
Results: In our material, the sensitivity of IgG anti-CagA antibody in identifying patients with a proven infection with the 
cagA-positive strains was 97.67%, and the negative likelihood ratios was 0.06. There was not significant correlation between 
serum IgA anti-CagA and the expression of the cagA gene among the dyspeptic patients. 
Conclusion: The IgG antibody titer was significantly higher in our patients with the cagA-positive H. pylori strain. How-
ever, in daily practice, the level of the IgG antibody titer cannot predict whether or not an individual carries a cagA-positive 
H. pylori strain, because there is a major overlap in the IgG antibody titer between the cagA-positive and cagA-negative 
patients. 
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INTRODUCTION
Helicobacter pylori is a Gram-negative, microaero-
philic bacterium that colonizes more than half of 
the world’s human population (1). Most individuals 
harboring H. pylori remain asymptomatic, but the 
presence of this organism is a risk factor for the de-
velopment of peptic ulceration, gastric mucosa-asso-
ciated lymphoid tissue lymphoma, and gastric ade-
nocarcinoma (2, 3). Several virulence factors of H. 
pylori have been frequently associated with the most 
serious clinical outcomes. These include the cytotox-
in-associated gene (cag) pathogenicity island, which 
encodes a protein that is injected into the cytoplasm 
of the host cell and induces cellular morphologic al-
terations, proliferation, adhesion, and apoptosis (3, 
4). The cagA gene is a marker for the presence of 
the cag pathogenicity island (5). The prevalence rates 
of the cagA gene in some developing and developed 
countries are reported to be as high as 60% and 90%, 
respectively (6). In addition, the prevalence rate of 
the cagA in Iranian patients with dyspepsia is re-
ported to be 68.5% (4). Given that the cagA-positive 
strain is more virulent, it can be postulated that the 
degree of inflammation will be more severe leading 
to a higher immunoglobulin G (IgG) antibody titer in 
patients with the cagA-positive H. pylori coloniza-
tion (7).
Several serological studies using the En-
zyme-Linked Immunosorbent Assay (ELISA) or 
Western Immunoblotting (WB) have been performed 
to detect antibodies against the cag antigens. The 
ELISA is widely used for the detection of antibodies 
in epidemiological and post-treatment studies. This 
serological test enables the detection of antibodies 
against specific H. pylori antigens such as the cagA 
and vacuolating cytotoxin gene A (vacA) antigens. 
More recently, the recombinant cagA has been used 
as an antigen in the ELISA for the specific serolog-
ical diagnosis of H. pylori infection in patients with 
peptic ulcer disease and non-ulcer dyspepsia (8, 9).
In the present study, we sought to detect specific 
IgG and IgA responses against the CagA of H. pylori 
in 130 patients with dyspepsia. Additionally, we tried 
to determine whether serum antibodies to CagA ac-
curately reflect the characteristics of infecting H. 
pylori strains with cagA gene positive  and to test 
the hypothesis that serum IgG and IgA have enough 
accuracy to select patients for endoscopy and gastric 
biopsy.
 
METHODS
  
    In the present study conducted between September 
2011-2012, 130 dyspeptic patients with positive H. py-
lori in histology and the chief complaint of dyspepsia 
of over 2 months duration referring to the endoscopy 
ward of Firoozgar Hospital were selected. According 
to Leeds Medical School criteria (10), 802 patients, 
aged between 15 and 65 years, were selected. All the 
patients provided informed consent and accepted to 
complete a standard questionnaire. Esophagogastro-
duodenoscopy was done for all the patients in the 
same center by expert endoscopists. Among these 
subjects, 130 H. pylori infected patients with dys-
pepsia, with or without peptic ulcers, were selected 
and included in the study. The eligibility of the pa-
tients was based on the results of the questionnaire 
and esophagogastroduodenoscopy. Those patient 
who  had no history of proved ulcer, previous H. py-
lori eradication, cigarette smoking, malignancy, and 
other underlying diseases in esophagogastroduode-
noscopy, and nor did they use proton pump inhibitors 
or antibiotics (from at least 2 months before endos-
copy) were excluded. Four biopsy specimens were 
taken from the antrum and gastric body for histolog-
ical study and H. pylori detection. All the formalin 
embedded  specimens were fixed and  stained with 
Hematoxylin and Eosin Stain (H&E) or Geimsa. The 
specimens were evaluated by an experienced  pathol-
ogist. A patient was considered  to be positive for 
H. pylori when at least 5 bacilli in each microscopic 
field were found. Five  ml of the blood sample was 
taken and sent to the immunology laboratory for an-
ti-CagA antibody measurement. The genomic DNA 
was extracted from the biopsy samples using a DNA 
isolation kit for cells and tissues (Roche Applied Sci-
ence Company) in according to the manufacturer's 
instruction and stored at -20°C. Two sets of  primers 
were designed complementary to the sequence locat-
ed within the conserved region of the gene primers: 
CagA1 and CagA2. The primers sequences and size 
are depicted in Table 1 (11). The amplified products 
were detected after agarose gel electrophoresis, and, 
a 340bp (base pair) and indicated the presence of the 
H. pylori CagA in the specimen, as is illustrated in 
Fig. 1. The identification  of gene product belong to 
H. pylori was confirmed via the PCR for the glmM, 
a conserved gene formerly known as urea C specif-
ic for this bacteria (11). Antibody measurement was 
performed using the commercial ELISA kit (Diag-
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nostic Bioprobes, Milano-Italy). The anti-CagA an-
tibody in the patients’ sera based on the synthetic 
CagA coated microplates. The complex was detected 
by 4RP conjugated antisera, and the color that devel-
oped was measured in 450-nm filters prefiltered at 
620 nm. The optical density (OD) of each well was 
measured, and the antibody level was calculated us-
ing a standard calibration curve. The method is both 
sensitive and specific (98%), and its diagnostic sen-
sitivity and specificity are more than 98%. A value ≥ 
5 Arb/ml was considered positive for the anti-CagA 
antibody.
The data were analysed using SPSS package (ver-
sion18) after encoding for each subject. Age is re-
ported as age ± standard deviation (SD). The serum 
anti-CagA antibody, IgG and IgA, and cagA gene 
were compared, and the sensitivity, specificity, posi-
tive likelihood ratios [sensitivity /(1-specificity)], and 
negative likelihood ratios[(1-sensitivity )/specificity] 
of the serum anti-CagA antibodies were calculated 
Table 1. Characteristics of the primers used for the detection of the cagA gene
Amplified 
Region
glmM
cagA1
cagA2
Primer 
Designation
GlmM-F      
GlmM-R
CAG1-F
CAG1-R
CAG2-F
CAG2-R
Primer Sequence
5´-AAGCTTTTAGGGGTGTTAGGGGTTT-3´
5´-AAGCTTACTTTCTAACACTAACGC-3´
5´- GAT AAC AGG CAA GCT TTT GAG G-3´
5´-CTG CAA AAG ATT GTT TGG CAG A-3´
5´ -TTG ACC AAC AAC CAC AAA CCG AAG-3´
5´ -CTT CCC TTA ATT GCG AGA TTC C -3´
Product Size
( bp )
294
349
1385
Ref.
11
11
11
cag, cytotoxin-associated gene; Bp, Base pair; glmM, urea C gene used for the detection of H. pylori; F, Forward; R, Reverse; 
CagA1 and A2, Two  pairs of primers used for the detection of the Cag; ref, references
Fig. 1. Cytotoxin-associated gene A-Positive and Negative 
Samples. Numbers indicate the  code of each patient.
for correlation. The results are presented with a con-
fidence interval (CI) of 95%. Statistical significance 
was compared between the serum anti-CagA anti-
body, IgG and IgA, and cagA gene,detected by PCR 
(cagA1, cagA2 positive or each one) using the Man-
tel-Haenszel chi-squared test  with Yates correction 
or Fisher exact probability test. A P-value less than 
0.05 was considered statistically significant
 
RESULTS
According to the Leeds Medical School crite-
ria, 802 patients had dyspepsia. The study popula-
tion was comprised of 469 (58.5%) females and 333 
(41.5%) males. The prevalence rate of H. pylori pos-
itive among these patients was 65.4%. Totally, 130 
H. pylori infected patients, with ulcer and non-ulcer 
dyspepsia, were selected based on the results of a 
questionnaire and esophagogastroduodenoscopy. Of 
these patients, 43 (33.1%) and 87 (66.9%) had cagA 
gene positive and negative, respectively. The average 
age was 42.9 ± 12.1 (16 to 64) years in the cagA gene 
positive patients and 40.9±14.7 (16-64) years in pa-
tients with cagA gene negative. 21 (48.8%) and 45 
(51.7%) of patients were female in cagA gene positive 
and negative patients, respectively (Table 2).
The IgG anti-CagA antibody level ranged between 
5 and 100Arb(Arbitrary)/ml. The mean±SD of the 
IgG anti-CagA antibody level in the patients with pos-
itive and negative cagA was 48.1±15.6 and 54.9 ±14.7, 
respectively. Also, the IgA anti-CagA antibody level 
ranged between 5 and 100Arb/ml. The mean± SD of 
the IgA anti-CagA antibody level in the patients with 
http://ijm.tums.ac.ir
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positive and negative cagA was 37 ± 9.4 and 51.5 ± 
15.9, correspondingly (Table 3). The frequency rate 
of the positive serum IgG anti-CagA antibody was 
96/130 (73.8%) in the entire study population and 
42/43 (97.7%) in the patients with the cagA. Addi-
tionally, the frequency rate of the positive serum IgG 
anti-CagA antibody was 54/87 (62.1%) among the 
cagA-negative patients. According to these results, 
the sensitivity, specificity, positive likelihood ratios, 
and negative likelihood ratios of the positive serolog-
ical results for the serum IgG anti-CagA antibody 
in the detection of the cagA gene were 97.96% (95% 
CI:86.20-99.87), 37.93% (95% CI:27.92-49.01), 1.57 
(95% CI:1.32 1.86), and 0.06 (95% CI:0.00-0.44), re-
spectively (Table 4). The frequency of the positive 
serum IgA anti-CagA antibody was 73/130 (56.1%) 
in the whole study population and 27/43 (62.8%) in 
the cagA-positive patients. Also, the frequency rate 
of positive serum IgA anti-CagA antibody was 46/87 
(52.9%) in the cagA-negative patients. According 
to these results, the sensitivity, specificity, positive 
likelihood ratios, and negative likelihood ratios of 
the positive serological results for the serum IgA an-
ti-CagA antibody in the detection of the cagA gene 
were 62.79% (95% CI:46.71-76.60), 47.12% (95% 
CI:36.44-58.07), 1.19 (95% CI:0.87-1.60), and 0.79 
(95% CI:0.52-1.19), respectively (Table 4).
DISCUSSION
   The determination of the IgG anti-CagA antibody 
may be a useful noninvasive method to identify infec-
tions caused by cytotoxic strains. In the present study, 
the sensitivity and the negative likelihood ratios of the 
serum IgG anti-CagA antibody in identifying patients 
Table 2. Demographic information of 130 patients with dys-
pepsia based on positive and negative cagA gene
Findings
Patients (n)
Age (year)
   Mean age ± SD
   Ranged
Female (n) 
Findings
   GU
   DU
   NUD
cagA genotypes
Positive (%)
43 (33)
42.9±12.1
16-64
21(48.8%)
11(25.6)
16(37.2)
16(37.2)
Negative (%)
87 (67)
40.9±14.7
16-64
45(51.7%)
16(18.4)
22(25.3)
49(56.3)
P-Value
0.12
0.77
-
-
-
cagA ;Cytotoxin-associated protein A gene, n; number, SD; 
standard deviation, GU; gastric ulcer, DU; duodenal ulcer, 
NUD; nonulcer dyspepsia
Table 3. Relationship between the Antibody Titer of IgG 
and IgA and the Presence of the CagA gene
cagA genotypes
Negative (%)
22 (40.7)
17 (31.5)
15 (27.8)
20 (43.5)
5 (10.9)
21 (45.6)
Positive (%)
15 (35.7)
10 (23.8)
17 (40.5)
6 (22.2)
2 (7.4)
19 (70.4)
Anti-CagA antibody 
Level
(Arb/ml)
High (69-100)
Medium(37-68)
Low(5-36)
High (69-100)
Medium(37-68)
Low(5-36)
IgG
IgA
CagA- Cytotoxin-associated protein; cagA, Cytotoxin-asso-
ciated protein A gene; IgG- Immunoglobulin G; IgA- Im-
munoglobulin A
Table 4. Accuracy of IgG and IgA Anti-CagA Antibody for diagnosis of cagA gene expression
P- Value
0.009
0.39
LR-
(95% CI)
0.06
(0.00-0.44)
0.79
(0.52- 1.19)
LR+
(95% CI)
1.57
(1.32-1.86)
1.19
(0.87- 1.60)
Specificity (%)
(95% CI)
37.93
(27.92-49.01)
47.12
(36.44- 58.07)
Sensitivity (%)
(95% CI)
97.67
(86.20-99.87)
62.79
(46.71-76.60)
cagA genotype
Negative (%)
54/87 (62)
33/87 (38)
46/87 (52.9)
41/87 (47.1)
Positive (%)
42/43 (97.7)
1/43 (2.3)
27/43 (62.8)
16/43 (37.2)
Anti-CagA 
Antibody
Positive
Negative
Positive
Negative
IgG
IgA
CagA; Cytotoxin-associated protein A, IgG; Immunoglobulin G, IgA; Immunoglobulin A, CI; confidence interval, LR+; pos-
itive likelihood ratios, R; negative likelihood ratios.
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with a proven infection with the cagA-positive strain 
were 97.67% and 0.06, respectively. In some of the 
cagA-negative patients,high levels of these antibodies 
were found, which is probably due to the immunolog-
ical background of a previous cagA-positive H. pylori 
infection. In contrast to a previous study, our results 
demonstrated that the seropositive IgA anti-CagA 
antibody in the cagA-negative patients was higher 
than that in their cagA-positive peers (12). Although 
the IgA anti-CagA antibodies are more detected in in 
cagA gene negative patients (46 vs 41), in our study, 
but the difference was not significant, on the other 
hand the IgG level disappear for longer time after bac-
terial elimination, for such a reason 54 patients remain 
IgG positive when the cagA gene disappeared.                        
    Serological experiments have shown that antibody 
titers with 120 to 128-kDa protein CagA correlate 
with the severity of the disease and that the CagA-pro-
ducing strains are associated with dyspepsia (13). 
Chronic H. pylori infection elicits local and systemic 
immunological responses, leading to the production 
of IgA and IgG antibodies. Host B cells are activated 
by both Th1 and Th2 cells via specific cytokines and 
responses involving immunoglobulins. Perez-Perez et 
al. showed that nearly all of their subjects had IgG re-
sponses to the CagA, whereas fewer subjects had IgA 
responses to the whole cell antigen and, thus, conclud-
ed that IgG responses to H. pylori antigens were more 
universal than those of IgA responses (14). In general, 
the measurement of the serum IgG antibody level is 
preferred because the level of this antibody reflects the 
infection status more accurately. It is worth bearing in 
mind that IgG can be detected against cytotoxin-as-
sociated proteins. Cytotoxin-associated proteins are 
highly immunogenic and usually stimulate immune 
response and can be detected by serological methods 
such as the ELISA and WB. More recently, the recom-
binant cagA has been used as an antigen according to 
the ELISA for the specific serological diagnosis of 
H. pylori infection in patients with peptic ulcer and 
non-ulcer dyspepsia (9). The recombinant cagA is able 
to predict the expression of the CagA at protein level, 
obviating the need for sequencing. Azuma et al. re-
ported that in their series of patients, some H. pylori 
strains possessed the CagA gene but were unable to 
produce the CagA protein and, thus, could be regarded 
as the cagA-negative strain (15).
    The diagnosis of H. pylori infection usually involves 
esophagogastricdoudenoscopy (EGD) with biopsy 
since the only noninvasive method of comparable ac-
curacy, the [13C] urea breath test, requires technical 
equipment that is not available in most  care health 
centers. However, in recent years, serological meth-
ods for detection of H. pylori infection have reached 
sufficient accuracy to be used as screening tests be-
fore EGD. Most of the commercially ELISA system 
available for serological surveys are based on the de-
tection of IgG antibodies against whole-cell prepara-
tions of H. pylori. Such preparations include antigens 
cross-reacting with other bacterial species, resulting in 
a specificity of these tests that rarely exceeds 90% (9).
The test-and-treat strategy is a new option adopted in 
the recent decade by primary care physicians at pri-
mary care health centers, especially centers lacking 
endoscopic facilities. Talley and Vakil suggested that 
the test-and-treat strategy is preferable in populations 
with moderate to high prevalence of H. pylori infec-
tion (≥ 10%) (16). Accordingly, the IgG anti-CagA 
antibody may be used  as a screening test instead of 
the conventional methods  of measurement of anti-H. 
pylori IgG antibodies which raised against crude  an-
tigen suspension to select high-risk patients admitted 
for dyspepsia without alarming signs for upper gastro-
intestinal endoscopy.
   Nevertheless, additional investigations with great-
er numbers of patients are required to fully elucidate 
whether there is an association between the serum 
IgG and IgA anti-CagA antibody and the cagA-posi-
tive strain. Moreover, some patients are infected with 
more than one type of bacteria possessing a variety of 
different proteins encoded by different genotypes of 
virulence genes. 
   In conclusion, our results suggest that a simple sero-
logical test such as ELISA could be helpful in identi-
fying subjects infected with H. pylori strains produc-
ing in vivo major bacterial virulence factors possibly 
involved in patients with dyspepsia. The use of a 
specific anti-H. pylori antibody assay, especially for 
the detection of a specific serum IgG against the cagA 
antigen, may help to better select patients for endosco-
py and gastric biopsy. The measurement of serum IgG 
anti-CagA antibody levels may be useful to select for 
upper endoscopy and  to  evaluate the eradication of 
the cagA-positive strain. 
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